Navigation Links
AEterna Zentaris Announces Appointment of New Board Member
Date:12/9/2009

.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are required by a governmental authority or applicable law.

SOURCE AETERNA ZENTARIS INC.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
2. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
3. AEterna Zentaris Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma
4. AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer
5. AEterna Zentaris Receives US$5.5 Million from Institutional Investors
6. AEterna Zentaris to Raise US$5.5 Million from Institutional Investors at US$1.20 Per Share
7. AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency
8. AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS-112 in Cancer
9. AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
10. AEterna Zentaris to Present at Upcoming Rodman Renshaw Annual Global Investment Conference
11. AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The Oklahoma tornado left the state with ... of Moore, one of the heavily damaged towns, proposed a ... cnn.com. Reaching out to also be of help, My Cleaning ... to counter the looming mold problem. , The disaster ... caused 24 deaths, My Cleaning Products shared. Ten of those ...
(Date:5/23/2013)... Mich. Every day, their baby stopped breathing, his ... his lungs. April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good ... Gionfriddo, about her now 20-month-old son, Kaiba. "At that ... would take it and run with it." , They ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Graphite ... self-lubricating bushings mounted in stainless steel pillow ... properties of GRAPHALLOY with the application and installation ... Steel Pillow Blocks work exceptionally well when ... or hostile liquids such as acids, alkalies, hydrocarbons, ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 The maker ... all types of inventions. They focus on learning practical ... this community gravitate toward bringing their ideas to life ... Biology Movement, works on making projects using biology. Glowing ... of plants to make them glow with bioluminescence genes, ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2
... Eiger BioPharmaceuticals, Inc.,a start-up biotechnology company developing antiviral ... a Series A financing co-led by InterWest,Partners and ... the formation,of the company and recruitment of its ... by general partners Nina Kjellson and Dr. Edgar ...
... group in Trinity,Biotech plc (Nasdaq: TRIB ), ... petitioned the Office of the Director of Corporate,Enforcement to ... communication between shareholders and prospective shareholders. , ... independent directors,Peter Coyne of Allied Irish Bank, and Dr. ...
... Inhibitor (human)] Commercial Launch --EXTON, Pa., Feb. 24 ViroPharma ... results for the fourth quarter and year ended December 31, ... , ... 2008; , Initiated commercial ...
Cached Biology Technology:Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 12
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes of ... TKF Foundation, will examine how collaborative planning and stewardship ... tragedy. , The TKF Foundation announced today that Landscapes ... grant funding. In addition to research on the role ... resiliency, the 3-year, $585,000 grant will contribute to the ...
(Date:5/22/2013)... Researchers working to improve durability in fuel cell ... University, have discovered links between electrode degradation processes ... quantifying the effects of electrode degradation stressors in ... membrane lifetime. , The findings of the study, ... the latest in a long-term study at Burnaby-based ...
(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Tests lead to doubling of fuel cell life 2
... Wan-chen Lee, a graduate student in Cornell University,s Dyson School ... phenomenon known as "the halo effect" for some time. Psychologists ... trait of a person can be influenced by how we ... words, the fact that a person has a positive attribute ...
... and diversification of the more than 300,000 living species ... earlier than previously calculated, a new study indicates. According ... State University and the lead author of the study, ... in the plant genome occurred hundreds of millions of ...
... team at the National Institutes of Health has identified a ... of a rare disorder. The syndrome is called periodic fever ... PFAPA and is characterized by monthly flare-ups of fever, ... The proposed treatment, which will be validated in a ...
Cached Biology News:The health halo effect: Don't judge a food by its organic label 2New genetic study helps to solve Darwin's mystery about the ancient evolution of flowering plants 2New genetic study helps to solve Darwin's mystery about the ancient evolution of flowering plants 3NIH researchers identify cause and new treatment for common recurrent fever in children 2NIH researchers identify cause and new treatment for common recurrent fever in children 3
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
QML offers standard and customized paraffin embedded tissue blocks....
Request Info...
Biology Products: